Back
Speaker illustration

Doctor Li Shen

Hanghou Normal University, Glasgow (China)

Member of:

Heart Failure Association

Presentations

Frailty and cognitive function in patients with heart failure and preserved ejection fraction: insights from PERSPECTIVE

Event: Heart Failure 2025

Topic: Comorbidities

Session: Heart failure, chronic kidney disease, and beyond: understanding risk, prognosis, and outcomes

Access
Like
Thumbnail

Qiliqiangxin improves cardiovascular outcomes in patients with heart failure and reduced ejection fraction irrespective of left ventricular ejection fraction

Event: Heart Failure 2025

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: ePosters in chronic heart failure - heart failure with HFrEF (2)

Access
Like
Thumbnail

Clinical correlates and prognostic impact of cognitive decline in patients with heart failure and preserved ejection fraction: insights from PARAGON-HF

Event: ESC Congress 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Delving deeper into HFpEF

Access
Like
Thumbnail

Blood pressure targets for patients with hypertension and heart failure

Event: ESC Congress 2024

Topic: Chronic Heart Failure

Session: Heart failure due to hypertension: innovative drug and device-based therapies

Access
Like
Thumbnail

Should a decline in eGFR to <30 mL/min always lead to discontinuation of an MRA?

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: Treating heart failure with diabetes and renal disease

Access
Like
Thumbnail

Cardiovascular and renal outcomes related to urinary albumin to creatinine ratio in patients with heart failure and reduced ejection fraction: A pooled analysis of ATMOSPHERE and PARADIGM-HF

Event: Heart Failure 2024

Topic: Biomarkers

Session: Chronic heart failure - biomarkers 1

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources